Malte H Wehmeyer - JoVE Visualize

Showing results (21-30 of 24) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 24 results.

Journal of Medical Virology|July 16, 2017

Real-world effectiveness of sofosbuvir-based treatment regimens for chronic hepatitis C genotype 3 infection: Results from the multicenter German hepatitis C cohort (GECCO-03)Malte H Wehmeyer, Patrick Ingiliz, Stefan Christensen, et al.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 19, 2016

Sofosbuvir and Ledipasvir for 8 Weeks for the Treatment of Chronic Hepatitis C Virus (HCV) Infection in HCV-Monoinfected and HIV-HCV-Coinfected Individuals: Results From the German Hepatitis C Cohort (GECCO-01)Patrick Ingiliz, Stefan Christensen, Torben Kimhofer, et al.

Gut|October 3, 2023

HLA-DPA1*02:01~B1*01:01 is a risk haplotype for primary sclerosing cholangitis mediating activation of NKp44+ NK cellsBritta F Zecher, David Ellinghaus, Sebastian Schloer, et al.

Journal of Hepatology|March 21, 2026

Integrative omics and phase IIa clinical trial identify TNF as key node in autoimmune hepatitisYang Xu, Jan Philipp Weltzsch, Christoph Kilian, et al.

Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 24 results.

Journal of Medical Virology|July 16, 2017

Real-world effectiveness of sofosbuvir-based treatment regimens for chronic hepatitis C genotype 3 infection: Results from the multicenter German hepatitis C cohort (GECCO-03)Malte H Wehmeyer, Patrick Ingiliz, Stefan Christensen, et al.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 19, 2016

Sofosbuvir and Ledipasvir for 8 Weeks for the Treatment of Chronic Hepatitis C Virus (HCV) Infection in HCV-Monoinfected and HIV-HCV-Coinfected Individuals: Results From the German Hepatitis C Cohort (GECCO-01)Patrick Ingiliz, Stefan Christensen, Torben Kimhofer, et al.

Gut|October 3, 2023

HLA-DPA1*02:01~B1*01:01 is a risk haplotype for primary sclerosing cholangitis mediating activation of NKp44+ NK cellsBritta F Zecher, David Ellinghaus, Sebastian Schloer, et al.

Journal of Hepatology|March 21, 2026

Integrative omics and phase IIa clinical trial identify TNF as key node in autoimmune hepatitisYang Xu, Jan Philipp Weltzsch, Christoph Kilian, et al.

Pageof 3